Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
RenovaroCube completes acquisition of Cyclomics to advance cutting-edge cancer diagnostics
Acquiring Company
Renovaro
Acquired Company
Cyclomics
Description
Renovaro Inc. (Nasdaq: RENB) has signed an agreement to acquire 100% ownership of Cyclomics, reinforcing their cutting-edge cancer diagnostics partnership. The acquisition reflects a shared commitment by Renovaro Inc. and Cyclomics to advancing state-of-the-art technologies in cancer diagnostics and treatment, positioning RenovaroCube to be a leader in early cancer diagnostics and monitoring of treatment efficacy.
Fundz sees it the moment Renovaro makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Cyclomics?
Cyclomics was acquired by Renovaro, based in Amsterdam. The deal was reported on April 24, 2024. Renovaro Inc. is a trailblazer in AI-driven early cancer diagnostics and therapeutics. Renovaro is privately held and operates in Biotechnology.
When did Renovaro acquire Cyclomics?
Renovaro's acquisition of Cyclomics was reported on April 24, 2024. Renovaro Inc. (Nasdaq: RENB) has signed an agreement to acquire 100% ownership of Cyclomics, reinforcing their cutting-edge cancer diagnostics partnership. The acquisition reflects a shared commitment by Renovaro Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cyclomics do?
Cyclomics is a leader in ultra-sensitive 4th generation multi-omics molecular biology. It is privately held, operating in Genetics, and is based in Utrecht.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.